Health2Sync-KY (慧康生技)* announced that Mitsubishi Heavy Industries (MHI) has renewed its contract for 2026, designating H2S as the sole provider for MHI’s "Diabetes Aggravation Prevention Program."

• Proven Efficacy: During the 2025 collaboration, H2S successfully helped MHI employees achieve significant improvements in HbA1c levels.
• Scale: The MHI health insurance association covers over 65,000 employees and 81,000 dependents.
• Digital Health Impact: This renewal reinforces the role of digital health coaching in clinical care, supporting MHI's goal of early intervention to reduce long-term medical expenditures.

Resource: 慧康生技、日本三菱重工續簽企業健保照護計畫 深化日本數位健康布局